Skip to main content

Personalized Medicine Gets Boost With New Prostate Cancer Finding

In a breakthrough with implications for new therapies, scientists have discovered five groups of prostate cancer, each with different DNA signatures.

Lead image for this article

In a breakthrough with implications for new therapies, scientists have discovered five groups of prostate cancer, each with different DNA signatures. That discovery means patients may get more customized treatment plans that will try to tackle their subtype. It’s another step toward personalized medicine and a shift from a one-size-fits-all treatment approach. (The Washington Post)




The Texas Tribune Member Drive Fall 2021 banner

Support public-service journalism that’s always free to read.

Yes, I'll donate today